1,061
Views
223
CrossRef citations to date
0
Altmetric
Research Article

The Comet Assay with Multiple Mouse Organs: Comparison of Comet Assay Results and Carcinogenicity with 208 Chemicals Selected from the IARC Monographs and U.S. NTP Carcinogenicity Database

, , , , , & show all
Pages 629-799 | Published online: 29 Sep 2008

REFERENCES

  • Tennant, R. W., B. H. Margolin, M. D. Shelby, E. Zeiger, J. K. Haseman, J. Spalding, and W. Caspary (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays, Science, 236, 933–41.
  • Zeiger, E., J. K. Haseman, M. D. Shelby, B. H. Margolin, and R. W. Tennant (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals, Environ. Mol. Mutagen., 16 (Suppl. 18), 1–14.
  • Morita, T., N. Asano, T. Awogi, Y. F. Sasaki, S. Sato, H. Shimada, S. Sutou, T. Suzuki, A. Wakata, T. Sofuni, and M. Hayashi (1997) Evaluation of the rodent micronucleus assay to screen IARC carcinogens (group 1, 2A, and 2B), The summary report of the 6th collaborative study by CSGMT/JEMS, Mutation Res., 389, 3–122.
  • Pool-Zobel, B. L., R. G. Klein, U. M. Liegibel, F. Kuchenmeister, S. Weber, and P. Schmezer (1992). Systemic genotoxic effects of tobacco-related nitrosoamines following oral and inhalation administration to Sprague-Dawley rats, Clin. Invest., 70, 299–306.
  • Singh, N. P., M. T. McCoy, R. R. Tice, and E. L. Schneider (1988). A simple technique for quantitation of low levels of DNA damage in individual cells, Exp. Cell. Res., 175, 184–191.
  • Fairbairn, D. W., P. L. Olive, and K. L. O'Neill (1995). The comet assay: a comprehensive review, Mutat. Res., 339, 37–59.
  • Schmezer, P., C. Eckert, and U. M. Liegibel (1994). Tissue-specific induction of mutations by streptozotocin in vivo, Mutat. Res., 307, 495–499.
  • Monteith, D. K. and J. Vanstone (1995). Comparison of the microgel electrophoresis assay and other assays for genotoxicity in the induction of DNA damage, Mutat. Res., 345, 97–103.
  • Singh, N. P., H. Lai, and A. Khan (1995). Ethanol-induced single-strand DNA breaks in rat brain cells, Mutat. Res., 345, 191–196.
  • Altamirano-Lozano, M., L. Alvarez-Barrera, F. Basurto-Alcanyara, M. Valverde, and E. Rojas (1996). Reprotoxic and genotoxic studies of vanadium pentaoxide in male mice, Terato. Carcino. Mutagenesis, 16, 7–17.
  • Singh, N. P., R. R. Tice, R. E. Stephens, and E. L. Schneider (1991). A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides, Mutat. Res., 252, 289–296.
  • Fairbairn, D. W., W. A. Reyes, and K. L. O'Neill (1994). Alkali-liable sites are prevalent in kidney tissue DNA, Cancer Lett. 81, 67–76.
  • Zheng, H. and P. L. Olive (1996). Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irraciation of SCCVII murine tumors and normal tissues, Cancer Res. 56, 2801–2808.
  • Sasaki, Y. F., S. Tsuda, F. Izumiyama, and E. Nishidate (1997a). Detection of chemically induced DNA lesions in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow) using the alkaline single cell gel electrophoresis (Comet) assay, Mutat. Res., 388, 33–44.
  • Sasaki, Y. F., F. Izumiyama, E. Nishidate, N. Matsusaka, and S. Tsuda (1997b). Detection of genotoxicity of rodent carcinogens targeting the liver by the alkaline single cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow), Mutat. Res., 391, 201–214.
  • Sasaki, Y. F., F. Izumiyama, E. Nishidate, N. Matsusaka, and S. Tsuda (1997c). Simple detection of genotoxicity of chemical mutagens by alkaline single cell gel electrophoresis (Comet) assay in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow), Mutat. Res., 391, 215–230.
  • Sasaki, Y. F., F. Izumiyama, E. Nishidate, T. Ohta, T. Ono, N. Matsusaka, and S. Tsuda (1997d). Simple detection of in vivo genotoxicity of pyrimethamine in rodents by the alkaline single cell gel elecyrophoresis assay, Mutat. Res., 392, 251–259.
  • Sasaki, Y. F., F. Izumiyama, E. Nishidate, M. Watanabe-Akanuma, N. Kinae, N. Matsusaka, and S. Tsuda (1997e). Detection of in vivo genotoxicity of 3- chloro-4- (dichloromethyl)-5-hydroxy-25H. -furanone (MX) by the alkaline single cell gel electrophoresis (Comet) assay in multiple mouse organs, Mutat. Res., 393, 47–53.
  • IARC (1987). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Over all Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France).
  • Ashby, J. and R. W. Tennant (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP, Mutat. Res., 257, 229–306.
  • Sasaki, Y. F., A. Saga, M. Akasaka, E. Nishidate, M. Watanabe-Akanuma, T. Ohta, N. Matsusaka, and Shuji Tsuda (1997f). In vivo genotoxicity of heterocyclic amines detected by alkaline single cell gel electrophoresis assay with mouse multiple organs, Mutat. Res., 395, 57–73.
  • Sasaki, Y. F., A. Saga, M. Akasaka, K. Yosida, E. Nishidate, Y. Q. Su, N. Matsusaka, and S. Tsuda (1997g). In vivo genotoxicity of ortho-phenylphenol, biphenyl and thiabendazole detected by alkaline single cell gel electrophoresis assay with mouse multiple organs, Mutat. Res., 395, 189–198.
  • Sasaki, Y. F., E. Nishidate, Y. Q. Su, N. Matsusaka, S. Tsuda, N. Susa, Y. Furukawa, and S. Ueno (1998a). Organ-specific genotoxicity of the potent rodent bladder carcinogens o-anisidine and p-cresidine, Mutat. Res., 412, 155–160.
  • Sasaki, Y. F., A. Saga, K. Yosida, Y. Q. Su., T. Ohta, N. Matsusaka, and S. Tsuda (1998b). Colon-specific genotoxicity of heterocyclic amines detected by the modified alkaline single cell gel electrophoresis assay of multiple mouse organs, Mutat. Res., 414, 9–14.
  • Sasaki, Y. F., A. Saga, M. Akasaka, S. Ishibashi, K. Yosida, Y. Q. Su, N. Matsusaka, and S. Tsuda (1998c). Organ-specific genotoxicity of the potent rodent colon carcinogen 1, 2-dimethylhydrazine and three hydrazine derivatives: difference between intraperitoneal and oral gavage, Mutat. Res., 415, 1–12.
  • Sasaki Y. F., A. Saga, M. Akasaka, S. Ishibashi, K. Yoshida, Y. Q. Su, N. Matsusaka, and S. Tsuda (1998d). Detection of in vivo genotoxicity of haloalkanes and haloalkenes carcinogenic to rodents by the alkaline single cell gel electrophoresis (comet) assay in multiple mouse organs, Mutat. Res., 419, 13–20.
  • Sasaki, Y. F., K. Fujikawa, K. Ishida, N. Kawamura, Y. Nishikawa, S. Ohta, M. Satoh, H. Madarame, S. Ueno, N. Susa, N. Matsusaka, and S. Tsuda (1999). The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP, Mutat. Res., 440, 1–18.
  • Tsuda, S. Y. Kosaka, N. Matsusaka, and Y. F. Sasaki (1998a). Detection of pyrimethamine-induced DNA damage in mouse embryo and maternal organs by the modified alkaline single cell gel electrophoresis assay, Mutat. Res., 415, 69–77.
  • Tsuda S., Y. Kosaka, M. Murakami, H. Matsuo, N. Matsusaka, K. Taniguchi, and Y. F. Sasak (1998b). Detection of nivalenol genotoxicity in cultured cells and multiple mouse organs by the alkaline single-cell gel electrophoresis assay, Mutat. Res., 415, 191–200.
  • Dunkel, V. C., E. Zeiger, D. Brusick, E. McCoy, D. McGregor, K. Mortelmans, H. S. Rosenkranz, and V. F. Shimmon (1984). Reproducibility of microsomal mutagenicity assays. I. Test with Salmonella typhumurium and Escherichia coli using standard protocol, Environ. Mutagen. 6 (S2) 1–254.
  • Shiraishi, Y. (1986). Hypersensitive character of Bloom syndrome B-lymphoblastoid cell lines usable sensitive carcinogen detection, Mutat. Res., 175, 179–187.
  • Watanabe, K. K. Sakamoto, and T. Sasaki (1995). Collaborative study of interlaboratory variability in Salmonella typhimurium TA102 and TA2638 and Escherichia coli WP2/pKM101 and WP2 uvrAlpKM101. Association of Microbial Mutation Testing Laboratory C.O., Mutagenesis, 10, 235–241.
  • MacCann J., N. E. Spingarn, J. Kobori, and B. N. Ames (1975). Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids, Proc. Natl. Acad. Sci. U.S.A., 72, 979–983.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). Mitomycin C (MMC), in: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 282.
  • CSGMT (1992). Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: The summary report of the 5th collaborative study by CSGMT/JEMSMMS, Mutat. Res., 278, 83–98.
  • IARC (1975). 2-Methyaziridine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 9, Lyon (France) pp. 61.
  • IARC (1976). Mitomycin C (MMC), in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 10, Lyon (France) pp. 171.
  • IARC (1990). Thiotepa, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 50, Lyon, (France) pp. 123.
  • McGregor, D. B., A. Brown, P. Cattanach, I. Edwards, D. McBride, and W. J. Caspary (1988). Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II. 18 coded chemicals, Environ. Mol. Mutagen., 11, 91–118.
  • Ishidate, M., Jr., M. C. Harnois, and T. Sofuni (1988). A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell culture, Mutat. Res., 195, 151–213.
  • IARC (1987). Epichlorohydrin, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 202.
  • IARC (1994). Propylene oxide, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 60, Lyon (France) pp. 181.
  • IARC (1994). Styrene-7,8-oxide, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 60, Lyon, (France) pp. 321.
  • IARC (1976). Diepoxybutane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 11, Lyon (France) pp. 175.
  • Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, and K. Mortelmans (1992). Salmonella mutagenicity tests. V. Results from the testing of 311 chemicals, Environ. Mol. Mutagen., 21 (Suppl. 19), 2–141.
  • Loveday, K. S., M. H. Lugo, M. A. Resnick, B. E. Anderson, and E. Zeiger (1989). Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. II. Results with 20 chemicals, Environ. Mol. Mutagen., 13, 60–94.
  • Gold, L. S., T. H. Slone, B. R. Stern, and L. Bernstein (1993). Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals, Mutat. Res., 286, 75–100.
  • Cliet, I., C. Melcion, and A. Cordier (1993) A lack of predictivity of bone marrow micronucleus test versus testis micronucleus test: comparison with four carcinogens, Mutat. Res., 292, 105–111
  • IARC (1976). ß-Butyrolactone, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 11, Lyon (France) pp. 265.
  • IARC (1974). 1,3-Propane sultone, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, Lyon (France) pp. 253.
  • IARC (1974). ß-Propiolactone, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, Lyon (France) pp. 259.
  • IARC (1987). Chlorambucil, in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 144.
  • IARC (1987). Melphalan, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 239.
  • IARC (1987). Cyclophosphamide, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 182.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). N-Ethyl-N-nitrosourea (ENU), in: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 194.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). N-Methyl-N-nitro-N′-nitrosoguanidine (MNNG), in: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 268.
  • Shibuya, T., T. Murota, and K. Tutikawa (1982). Mouse spot tests with alkylnitrosoureas, Mutat. Res., 104, 311–315.
  • IARC (1978). N-Ethyl-N-nitrosourea (ENU), in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 191.
  • IARC (1987). N-Methyl-N-nitro-N′-nitrosoguanidine (MNNG), In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Over all Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 248.
  • IARC (1978). N-Nitrosodi-n-butylamine (DBN), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 51.
  • IARC (1978). N-Nitrosodiethylamine (DEN), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 83.
  • IARC (1978). N-Nitrosodimethylamine (DMN), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 125.
  • IARC (1978). N-Nitrosodiethanolamine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 77.
  • IARC (1978). N-Nitrosodi-n-propylamine (DPN), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 177.
  • IARC (1978) N-Nitrosodi-n-propylamine (DPN), in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp.221.
  • IARC (1978). N-nitrosomorpholine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 263.
  • IARC (1978). N-Nitrosopiperidine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 287.
  • IARC (1978). N-Nitrosopyrrolidine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 17, Lyon (France) pp. 313.
  • IARC (1992). Diethyl sulfate, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 54, Lyon (France) pp. 213.
  • IARC (1987). Dimethyl sulfate, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 200.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). Ethyl methanesulfonate (EMS), In: Environmental Mutagens Data Book No.C 1, Scientist Inc., Tokyo, pp. 191.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). Methyl methanesulfonate (MMS), In: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 263.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980) Busulfan (BUS), In: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 80.
  • IARC (1974). Ethyl methanesulfonate (EMS), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 7, Lyon (France) pp. 245.
  • IARC (1974). Methyl methanesulfonate (MMS), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 7, Lyon (France) pp. 253.
  • IARC (1974). 1, 4-Butanediol dimethanesulfonate (Myleran) (BUS), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, Lyon (France) pp. 247.
  • IARC (1974). Urethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 7, IARC, Lyon (France), pp. 111.
  • IARC (1989). Dimethyl formamide, In: IARC Mono graphs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 47, Lyon (France) pp. 171.
  • IARC (1974). Methylthiouracil, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 7, IARC, Lyon (France), pp. 53.
  • Mavournin, K. H., D. H. Blakey, M. C. Cimino, M. F. Salamone, and J. A. Heddle (1990). The in vivo micronucleus assay in mammalian bone marrow and peripheral blood, a report of the U.S. Environmental Protection Agency Gene-Tax Program, Mutat. Res., 239, 29–80.
  • IARC (1994). Acrylamide, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 60, Lyon (France) pp. 389.
  • IARC (1987). Ethylene thiourea, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 207.
  • IARC (1987). Acetamide, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1-42, IARC, Lyon (France), pp. 389.
  • IARC (1974). Thioacetamide, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 7, Lyon (France) pp. 77.
  • Anderson, R. S., J. E. Doos, and F. L. Rose (1982). Differential ability of Ambystoma tigtinum hepatic microsomes to produce mutagenic metabolites from polycyclic aromatic hydrocarbons and aromatic amines, Cancer Lett., 16, 33–41.
  • IARC (1982). 3, 3′-Dichlorobenzidine and its dihydrochloride, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 29, IARC, Lyon (France) pp. 238–256.
  • IARC (1982). Benzidine and its sulfate, hydrochloride and dihydrochloride, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 29, IARC, Lyon (France), pp. 149.
  • IARC (1978). N,N′-Diacetylbenzidine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 16, IARC, Lyon (France), pp. 293–399.
  • Sugimura, T. (1982). Mutagens, carcinogens and tumor promoters in our daily food, Cancer, 49, 1970-1984.
  • Felton, J. S., M. G. Knize, N. H. Shen, B. D. Andersen, L. F. Bjeldanes, and F. T. Hatch (1986). Identification of the mutagens in cooked beef, Environ. Health Perspect., 67, 17–24.
  • IARC (1993) MeIQx, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 56, IARC, Lyon (France), pp. 93.
  • IARC (1993). IQ, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 56, IARC, Lyon (France), pp. 165.
  • IARC (1993). PhIP, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 56, IARC, Lyon (France), pp. 229.
  • Sawada, S., T. Yamanaka, K. Yamatsu, C. Furihata, and T. Matsushima (1991). Chromosome aberrations, micronuclei and sister-chromatid exchanges (SCEs) in rat liver induced in vivo by hepatocarcinogens including heterocyclic amines, Mutat. Res., 251, 59–69.
  • Sugimura, T. (1988). Successful use of short-term tests for academic purposes: their use in identification of new environmental carcinogens with possible risk for humans, Mutat. Res., 205, 33–39.
  • Sugimura, T., S. Takayama, H. Ohgaki, K. Wakabayashi, and M. Nagao (1990). Mutagens and carcinogens formed by cooking meat and fish: hetero cyclic amines, In: P. A. Finot, H. U. Aeschbacher, R. F. Hurrell, and R. Liardon Eds., The Maillard Nutrition and Physiology, Birkhaeuser Verlag, Basel, pp. 323–334.
  • Alexander, J., G. Becher, and L. Busk (1989). Cooked food mutagens — a general overview, Var. Foda, 42 (Suppl. 2), 9–59.
  • Overvik, E. and J. A. Gustafsson (1990). Cooked food mutagens: current knowledge of formation and biological significance, Mutagenesis, 5, 437–446.
  • Esumi, H., H. Ohgaki, E. Kohzen, S. Takayama, and T. Sugimura (1989). Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Jpn. J. Cancer Res., 80, 1176–1178.
  • Weisburger, J. H., A. Rivernson, J. Reinhaedt, C. Aliaga, J. Braley, L. M. Dolan, G. M. Wiliams, E. Zang, D. G. Kingston, and M. Bashir (1994). Genotoxicity and carcinogenicity in rats and mice of 2-amino-3, 6-dihydro-3-methyl-7H-imidazo4,5-f. quinoline-7-one (IQ): an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo4,5-f. quinoline (IQ), J. Natl. Cancer Inst., 86, 25–30.
  • Nagao, M. and T. Sugimura (1993). Carcinogenic factors in food with relevance to colon cancer development, Mutat. Res., 290, 43–51.
  • IARC (1982). 4,4′-Diaminodiphenyl ether, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 29, IARC, Lyon (France), pp. 203–212.
  • IARC (1986). 4,4′-Methylenedianiline (XE “4,4′-Methylenedianiline” “Methylenedianiline”) and its dihydrochloride, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 39, IARC, Lyon (France), pp. 347–365.
  • IARC (1987). Auramine, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1-42, IARC, Lyon (France), pp. 118.
  • IARC (1993). 4,4′-Methylenebis(2-chloroaniline) (MOCA), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 271–303.
  • IARC (1982). 4,4′-Thiodianiline, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 27, IARC, Lyon (France), pp. 147–154.
  • IARC (1993). para-Chloroaniline, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 305.
  • IARC (1990). para-Chloro-ortho-toluidine and its strong acid salts, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 48, IARC, Lyon (France), pp. 123–137.
  • IARC (1982). 4-Chloro-ortho-phenylenediamine and 4-chloro-meta-phenylenediamine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 27, IARC, Lyon (France), pp. 81–89.
  • IARC (1978). 2,4-Diaminotoluene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 16, IARC, Lyon (France), pp. 83–95.
  • IARC (1978). 2,5-Diaminotoluene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 16, IARC, Lyon (France), pp. 97.
  • Mirsalis, J. C., C. K. Tyson, and B. E. Butterworth (1982). Detection of genotoxic carcinogens in the in vivo-in vitro hepatocyte DNA repair assay, Environ Mutagen., 4, 553–562.
  • Miyagawa, M., H. Takasawa, A. Sugiyama, Y. Inoue, T. Murata, Y. Uno, and K. Yoshikawa (1995). The in vivo-in vitro replicative DNA synthesis (RDS) test with hepatocytes prepared from male B6C3F1 mice as an early prediction assay for putative nongenotoxic (Ames-negative) mouse hepatocarcinogens, Mutat. Res., 343, 157–183.
  • IARC (1982). 2,4-Diaminoanisole and 2,4- diaminoanisole sulphate, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 27, IARC, Lyon (France), pp. 103–117.
  • IARC (1987). Aniline, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42., IARC, Lyon (France), pp. 99.
  • Westmoreland, C. and D. G. Gatehouse (1991). Effects of aniline hydrochloride in the mouse bone marrow micronucleus test after oral administration, Carcinogenesis, 12, 1057–1059.
  • IARC (1993). 2,6-Dimethylaniline (2,6-Xylidine), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 323.
  • Parton, J. W., J. E. Beyers, M. L. Garriott, and R. N. Tamura (1990). The evaluation of a multiple dosing protocol for the mouse bone-marrow micronucleus assay using benzidine and 2,6-xylidine, Mutat. Res., 234, 165–168.
  • IARC (1982). ortho-Toluidine and ortho-toluidine hydrochloride, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 27, IARC, Lyon (France), pp. 155–175.
  • IARC (1980). Phenacetin, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 24, IARC, Lyon (France), pp. 135.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). 2- Acetylaminofluorene (2AAF), In: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 18.
  • IARC (1987). 2-Naphthylamine, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1-42., IARC, Lyon (France), pp. 261–263.
  • IARC (1987). 1-Naphthylamine, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42., IARC, Lyon (France), pp. 260.
  • Potot, H. C., III and Y. P. Dragan (1996). Chemical carcinogenesis, In: Klaassen, C. D. Ed. Casarett and Doull's Toxicology the Basic Science of Poisons, 5th ed., McGraw-Hill, New York, pp. 201–267.
  • Ishidate, M. Jr, T. Sofuni, K. Yoshikawa, M. Hayashi, T. Nohmi, M. Sawada, and A. Matsuoka (1984). Primary mutagenicity screening of food additives currently used in Japan, Food Chem. Toxicol., 22, 623–36.
  • IARC (1993). Magenta and CI Basic Red 9, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 215.
  • IARC (1978). Fast Green FCF, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 16, IARC, Lyon (France), pp. 187.
  • IARC (1974). Magenta, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, IARC, Lyon (France), pp. 57–64.
  • IARC (1990). Disperse Blue 1, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 48, IARC, Lyon (France), pp. 139.
  • Zeiger, E., B. Anderson, S. Haworth, T. Lawlor, K. Mortelmans, and W. Speck (1987). Salmonella mutagenicity tests, III. Results from the testing of 255 chemicals, Environ. Mutagen., 9 (Suppl. 9), 1–109.
  • Combes, R. D. and R. B. Haveland-Smith (1982). A review of the genotoxicity of food, drug and cosmetic colours and other azo, triphenylmethane and xanthene dyes, Mutat. Res. 98. 101–248.
  • Salamone, M. F., J. A. Heddle and M. Katz (1987). Mutagenic activity of 41 compounds in the in vivo micronucleus test, In: F. J. de Serres and J. Ashby Eds., Evaluation of Short-Term Tests for Carcinogens, Elsevier, New York, pp. 686–697.
  • IARC (1987). p-Aminoazobenzene, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1-42, IARC, Lyon (France), pp. 390.
  • IARC (1975). o-Aminoazotoluene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), 61.
  • IARC (1975). p-Dimethylaminoazobenzene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 125–139.
  • IARC (1990). Dieperse Yellow 3, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 48, IARC, Lyon (France), 149.
  • IARC (1975). Azobenzene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), 75.
  • IARC (1993). CI Pigment Red 3, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 259.
  • IARC (1975). Sudan I, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 225.
  • IARC (1975). Oil Orange SS, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 165.
  • IARC (1975). Ponceau SX, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 207.
  • Prival, M. J., S. J. Bell, V. D. Mitchell, M. D. Peiperl, and V. L. Vaughan (1984). Mutagenicity of benzidine and benzidine-congener dyes and selected monoazo dyes in a modified Salmonella assay, Mutat. Res., 136, 33–47.
  • IARC (1975). Ponceau 3R, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 199.
  • IARC (1975). Orange I, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 173.
  • IARC (1975). Amaranth, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 41.
  • IARC (1975). Orange G, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 181.
  • IARC (1975). Sudan II, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 233.
  • IARC (1975). Sudan III, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 241.
  • IARC (1975). Sudan Red 7B, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 253.
  • IARC (1987). Benzidine-based dyes, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 125.
  • IARC (1993). CI Direct Blue 15, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 235.
  • IARC (1993). CI Acid Red 114, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 57, IARC, Lyon (France), pp. 247.
  • Robertson, J. A., W. J. Harris, and D. B. McGregor (1982) Mutagenicity of azo dyes in the Salmonella/ activation test, Carcinogenesis, 3, 21–25
  • Cameron T. J., P. E. Kirby, V. A. Fung, and V. C. Dunkel (1987). VC Mutagenic activity of 27 dyes and related chemicals in the Salmonella/microsome and mouse lymphoma TK+/- assays, Mutat. Res., 189, 223–261
  • IARC (1975). Evans Blue, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 151.
  • IARC (1975). Trypan Blue, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 8, IARC, Lyon (France), pp. 267.
  • IARC (1987). Dacarbazine, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 184.
  • IARC (1987). Phenazopyridine hydrochloride, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Mono graphs from Vols. 1-42, IARC, Lyon (France), pp. 312.
  • IARC (1983). AF-2 2-(2-Furyl)-3-(5-nitro-2- furyl)acrylamide., In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 31, IARC, Lyon (France), pp. 47.
  • IARC (1987). Methoronidazole, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 250.
  • Kada, T. and M. Ishidate, Jr. Ed. (1980). 4- Notroquinoline 1-oxide (4NQO), In: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 310.
  • CSGMT (1986). Sex difference in the micronucleus test. The Collaborative Study Group for the Micronucleus Test, Mutat. Res., 172, 151–63.
  • Takahashi, K., Y. Kawazoe, M. Tada, M. N. Ito, and M. Okada (1978). Carcinogenicity of 4-nitrosoquinoline 1 -oxide and its possible role in carcinogenesis by 4-nitroquinoline 1-oxide, Gann, 69, 499–505.
  • Kitano, M., H. Hatano, and H. Shisa (1992). Strain difference of susceptibility to 4-nitroquinoline 1-oxide-induced tongue carcinoma in rats, Jpn. J. Cancer Res., 83, 843–50.
  • IARC (1989). 1,8-Dinitropyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 46, IARC, Lyon (France), pp. 231.
  • IARC (1989). 1,6-Dinitropyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 46, IARC, Lyon (France), pp. 215.
  • IARC (1989). 1,3-Dinitropyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 46, IARC, Lyon (France), pp. 201.
  • IARC (1989). 1-Nitropyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 46, IARC, Lyon (France), pp. 321.
  • IARC (1989). 2-Nitrofluorene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 46, IARC, Lyon (France), pp. 277.
  • IARC (1990). Chloramphenicol, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 50, IARC, Lyon (France), pp. 169.
  • IARC (1978). 5-Nitroacenaphthene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 16, IARC, Lyon (France), pp. 379.
  • IARC (1983). Nitrofen, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 30, IARC, Lyon (France), pp. 271.
  • IARC (1991). Chlorodibromomethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 52, IARC, Lyon (France), pp. 243.
  • IARC (1987). Dichloromethane, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 194.
  • IARC (1987). Carbon tetrachloride, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, TARC, Lyon (France), pp. 143.
  • IARC (1987). Chloroform, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 152.
  • IARC (1987). 1,2-Dibromo-3-chloropropane, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 191.
  • IARC (1987). Ethylene dibromide, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 204.
  • IARC (1979). 1,2-Dichloroethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 20, IARC, Lyon (France), pp. 429.
  • IARC (1987). Hexachlorocyclohexanes, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 204.
  • IARC (1979). Hexachloroethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 20, IARC, Lyon (France), pp. 467.
  • IARC (1986). Pentachloroethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 41, IARC, Lyon (France), pp. 99.
  • IARC (1986). 1,1,1,2-Tetrachloroethane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol 41, IARC, Lyon (France), pp. 87.
  • IARC (1987). 1,1,2,2-Tetrachloroethane, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 354.
  • Sasaki, Y. F., H. Imanishi, M. Watanabe, A. Sekiguchi, M. Moriya, Y. Shirasu, and K. Tutikawa (1986). Mutagenicity of 1,2-dibromo-3-chloropropane (DBCP) in the mouse spot test, Mutat. Res., 174, 145–147.
  • Søderlund, E. J., M. Låg, J. A. Holme, G. Brunborg, J. G. Omichinski, J. E. Dahl, S. D. Nelson, and E. Dybing (1990). Species differences in kidney necrosis and DNA damage, distribution and glutathione-dependent metabolism of 1,2-dibromo-3-chloropropane (DBCP), Pharmacol. Toxicol., 66, 287–293.
  • Låg, M, E. J. Søderlund, G. Brunborg, J. E. Dahl, J. A. Holme, J. G. Omichinski, S. D. Nelson, and E. Dybing (1989). Species differences in testicular necrosis and DNA damage, distribution and metabolism of 1,2-dibromo-3-chloropropane (DBCP), Toxicology, 58, 133–144.
  • Arfellini, G., S. Bartoli, A. Colacci, M. Mazzulo, M. C. Galli, G. Prodi and S. Grilli (1984) In vivo and in vitro binding of 1,2-dibromoethane and 1,2- dichloroethane to macromolecules in rat and mouse organs, J. Cancer Res. Cln. Oncol., 108, 204–213.
  • IARC (1986). 1,3-Dichloropropene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 41, IARC, Lyon (France), pp. 113.
  • ARC (1986). Vinyl bromide, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 39, IARC, Lyon (France), pp. 133.
  • IARC (1995) Tetrachloroethylene, in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 63, IARC, Lyon (France), pp. 159.
  • IARC (1995). Trichloroethylene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 63, IARC, Lyon (France), pp. 75.
  • Sasaki, Y. F., H. Imanishi, M. Watanabe, T. Ohta, Y. Shirasu, and T. Tutikawa (1986) Mutagenicity evaluation of pesticides in the mouse spot test, Annual Meeting of the Japanese Environmental Mutagen Society (Tokyo).
  • Kevekordes, S., T. Gebel, K. Pav, R. Edenharder, and H. Dunkelberg (1996). Genotoxicity of selected pesticides in the mouse bone-marrow micronulceus test and in the sister-chromatid exchange test with human lymphocytes in vitro, Toxicol. Lett., 89, 35–42.
  • IARC (1991). Captafol, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 53, IARC, Lyon (France), pp. 353.
  • IARC (1987). Bis(chloromethyl)ether and chloromethyl methyl ether (technical-grade), in: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 59.
  • IARC (1991). Dichlorvos, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 53, IARC, Lyon (France), pp. 353.
  • Meier, J. R., W. F. Blazak, R. B. Knohl (1987). Mutagenic and clastogenic properties of 3-chloro-4- (dichloromethyl)-5-hydroxy-25H-furanone: a potent bacterial mutagen in drinking water, Environ. Mol. Mutagen., 10, 411–424.
  • IARC (1987). Aldrin, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 88.
  • IARC (1991). Chlordane and heptachlor, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 53, IARC, Lyon (France), pp. 115.
  • IARC (1987). Dieldrin, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 196.
  • IARC (1995). Trichloroacetic acid, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 63, IARC, Lyon (France), pp. 291.
  • Komulainen, H. V. M. Kosma, S. L. Vaittinen, T. Vartiainen, E. Kaliste Korhonen, S. Ljen, R. K. Tuominen, and J. Tuomisto (1997). Carcinogenicity of the drinking water mutagen 3-chloro-4- (dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat, J. Natl. Cancer Inst., 89, 848–856.
  • IARC (1991). DDT and associated compounds, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 53, IARC, Lyon (France), pp. 179.
  • Ashby J. and D. Paton (1993). The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures, Mutat. Res., 286, 3–74.
  • IARC (1987). ortho-Dichlorobenzene and para-dichlorobenzene, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 192.
  • IARC (1987). Hexachlorobenzene, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 219.
  • IARC (1987). Chlorophenols, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. IARC, Lyon (France), pp. 154.
  • IARC (1987). Pentachlorophenol, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 53, IARC, Lyon (France), pp. 371.
  • IARC (1987). Polychlorinated biphenyls (PCBs), In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 322.
  • IARC (1987). Diethylstilboestrol (DES), In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1-42, IARC, Lyon (France), pp. 273.
  • IARC (1987). Oestrogens, nonsteroidal, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 273.
  • IARC (1987). Oestrogens, steroidal, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 280.
  • IARC (1987). Androgenic steroid, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 96.
  • Gold, L. S., T. H. Slone, B. R. Stern. and L. Bernstein (1993). Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals, Mutat. Res., 286, 75–100.
  • IARC (1987). Hydrazine, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), 223–224.
  • MacCann, J. E., E. Choi, E. Yamasaki, and B. N. Ames (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals, Proc. Natl. Acad. Sci. U.S.A., 72, 5135–5139.
  • MacCann, J. and B. N. Ames (1976). Detection of carcinogens as mutagens in the salmonella/microsome test: assay of 300 chemicals: discussion, Proc. Natl. Acad. Sci. U.S.A., 73, 950–954.
  • Ishidate, M., Jr. Ed. (1987). Data Book of Chromosomal Aberration Tests in vitro, L.I.C. Inc., Tokyo, pp. 141.
  • Lee, I. P. and R. L. Dixon (1978). Mutagenicity, carcinogenicity and teratogenicity of procarbazine, Mutat. Res., 55, 1–14.
  • IARC (1974). 1,2-Dimethylhydrazine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, IARC, Lyon (France), pp. 145.
  • IARC (1974). 1,1-Dimethylhydrazine, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 4, IARC, Lyon (France), pp. 137.
  • IARC (1987). Cisplatin, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 170.
  • IARC (1990). Chromium and chromium compounds, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 49, IARC, Lyon (France), pp. 49.
  • IARC (1987). Arsenic and arsenic compounds, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 100.
  • IARC (1993). Cadmium and cadmium compounds, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 58, IARC, Lyon (France), pp. 119.
  • IARC (1990). Nickel and nickel compounds, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 49, IARC, Lyon (France), pp. 257.
  • IARC (1987). Lead and lead compounds, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 230.
  • IARC (1993). Beryllium and beryllium compounds, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 58, IARC, Lyon (France), pp. 41.
  • Tice, R. R., J. W. Yager, P. Andrews, and E. Crecelius (1997). Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite, Mutatio Res., 386, 315–34.
  • IARC (1983) Benz [a] anthracene, in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp. 135.
  • IARC (1983). Benzo[a]pyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp.211.
  • IARC (1983). Benzo[j] fluoranthene, in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp. 155.
  • IARC (1983). Benzo[b]fluoranthene, in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp. ?.
  • IARC (1983). Benzo[e]pyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp. 225.
  • IARC (1983). Pyrene, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 32, IARC, Lyon (France), pp. 431.
  • Kada, T. and M. Ishidate Jr. Ed. (1980). 7,12- Dimethylbenz[a]anthracene (DMBA), in: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 160.
  • Akamatsu, Y. (1975). Neoplasms in strains of splenectomized mice after a single 7, 12- dimethylbenz[alpha]anthracene treatment, J. Natl. Cancer Inst., 55, 893–897.
  • Parkinson, A. (1996). Biotransformation of xenobiotics, In: Klaassen, C. D., Ed. Casarett and Douli's Toxicology the Basic Science of Poisons, 5th ed., McGraw-Hill, New York, pp. 113–186
  • IARC (1995). Benzfuran, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 63, IARC, Lyon (France), pp. 431.
  • Hastie, A. C. and S. G. Georgopoulos (1971). Mutational resistance to fungitoxic benzimidazole derivatives in Aspergillus nudulans, J. Gen. Microbiol., 67, 371–373.
  • Seiler, J. P. (1972). Mutagenicity of benzimidazole and benzimidazole derivatives, I. Forward and reverse mutations in Salmonella typhimurium caused by benzimidazole and some its derivatives, Mutat. Res., 15, 273–276.
  • Kappas, A., S. G. Georgopoulos, and A. C. Hastie (1974). On the genetic activity of benzimidazole and thiophanate fungicides on diploid Aspergillus nudulans, Mutat. Res., 26, 17–27.
  • Ogata, A., H. Ando, K. Kubo, and K. Hiraga, Teratogenicity of thiabendazole in ICR mice, Food Chem. Tocxicol., 22, 509–520.
  • Seiler, J. P. (1972). The mutagenicity of benzimidazole compounds, Mutat. Res., 32, 151–168.
  • Seiler, J. P. (1976). The mutagenicity of benzimidazole derivatives, VI. Cytogenetic effects of benzimidazole derivatives in the bone marrow of the mouse and in the Chinese hamster, Mutat. Res., 40, 339–348.
  • Mundry de Pargament, M. D., M. Labal de Vinuesa and I. Larripa (1987). Mutagenic bioassay of certain pharmacological drugs, I. Thiabendazole (TBZ), Mutat. Res., 188, 1–6.
  • von Borstel, R. C. and J. A. Higgins (1998). Janus carcinogens and mutagens, Mutat. Res., 402, 321–329.
  • IARC (1985). Acetaldehyde, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 36, IARC, Lyon (France), pp. 101.
  • IARC (1987). Acrylonitrile, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 79.
  • IARC (1986) Ethyl acrylate, in: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 39, IARC, Lyon (France), pp. 81.
  • IARC (1982). 2-Nitropropane, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 29, IARC, Lyon (France), pp. 331.
  • Deng, X. S., J. Tuo, H. E. Poulsen, and S. Loft (1997). 2-Nitropropane-induced DNA damage in rat bone marrow, Mutation Res., 391, 165–169.
  • Kada, T. and M. Ishidate Jr. Ed. (1980). Dimethyl sulfoxide (DMSO), in: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 282.
  • Urban, H. (1976). Tumorigenicity of trinitrosotrimethylene triamine dissolved in dimethyl sulfoxide (DMSO), Arch. Geschwulstforsch, 46, 657–662.
  • IARC (1976). Daunomycin, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 10, IARC, Lyon (France), pp. 145.
  • IARC (1986). Butylated hydroxyanisole (BHA), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 40, IARC, Lyon (France), pp. 123.
  • IARC (1986). Butylated hydroxytoluene (BHT), In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 40, IARC, Lyon (France), pp. 161.
  • IARC (1989). Phenol, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 47, IARC, Lyon (France), pp. 263.
  • IARC (1983). ortho-Phenylphenol and its sodium salt, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 30, IARC, Lyon (France), pp. 329.
  • Pathak, D. N. and D. Roy (1993) In vivo genotoxicity of sodium o-phenylphenol: phenylbenzoquinone is one of the DNA-binding metabolite(s) of sodium o- phenylphenol, Mutat. Res., 286, 309–319.
  • IARC (1987). Benzene, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 120.
  • IARC (1986). Benzyl acetate, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 40, IARC, Lyon (France), pp. 109.
  • IARC (1982). Di(2-ethylhexyl) phthalate, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 29, IARC, Lyon (France), pp. 269.
  • IARC (1995). Formaldehyde, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 62, IARC, Lyon (France), pp. 217.
  • IARC (1987). Bleomycins, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 134.
  • IARC (1977). 8-Hydeoxyquinoline, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 13, IARC, Lyon (France), pp. 101.
  • IARC (1987). Phenobarbital, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 313.
  • Gocke, E., M. T. King, K. Echhardt, and D. Wild (1981). Mutagenicity of cosmetics ingredients licensed by the European Communities, Mutat. Res., 90, 91–109.
  • IARC (1987). 1,4-Dioxian, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 201.
  • IARC (1995). Fulfural, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 63, IARC, Lyon (France), pp. 409.
  • IARC (1987). Caprolactam, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 390.
  • IARC (1987). 5-Fluorouracil, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 210.
  • Kada, T. and M. Ishidate Jr. Ed. (1980). Cytarabine, In: Environmental Mutagens Data Book No. 1, Scientist Inc., Tokyo, pp. 118.
  • IARC (1986). Potassium bromate, In: IARC Monographs on the Evaluation of Carcinogenesis Risk of Chemicals to Man, Vol. 40, IARC, Lyon (France), pp. 207.
  • IARC (1987). Tobacco smoke, In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity, An Updating of IARC Monographs from Vols. 1–42, IARC, Lyon (France), pp. 359.
  • Lee, C. K., B. G. Brown, E. A. Reed, G. D. Lowe, S. C. McKarns, C. W. Fulp, C. R. Coggins, P. H. Ayres, and D. J. Boolittle (1990). Analysis of cytogenetic effects in bone marrow cells of rats subcuronically exposed to smoke cigarettes which bum or only heat tabacco, Mutat. Res., 240, 251–257.
  • Miyamae, Y., K. Zaizen, K. Ohara, Y. Mine, and Y. F. Sasaki (1997). Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (Comet) assay: I. Relationship between the onset of DNA damage and the characteristics of mutagens, Mutat. Res., 393, 99–106.
  • Miyamae, Y., K. Iwasaki, N. Kinae, S. Tsuda, M. Murakami, M. Tanaka, and Y. F. Sasaki (1997). Detection of DNA lesions induced by chemical mutagens using the single cell gel electrophoresis (SCG) assay: II. Relationship between DNA migration and alkaline condition, Mutat. Res., 393, 107–113.
  • Ames, B. N., M. K. Shigenaga, and L. S. Gold (1993). DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis, Environ. Health Perspect., 101 (Suppl. 5), 35–44.
  • Tennant, R. W. and E. Zeiger (1993). Genetic toxicology: current status of methods of carcinogen identification, Environ. Health Perspect., 100, 307–315.
  • Hayashi, M., S. Sutou, H. Shimada, S. Sato, Y. F. Sasaki, and A. Wakata (1989). Difference between intraperitoneal and oral gavage application in the micronucleus test: the 3rd collaborative study by CSGMT/JEMS.MMS. Collaborative Study Group for the Micronucleus Test/Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan, Mutat. Res., 223, 329–344.
  • Albanse, R., E. Mirkova, D. Gatehouse, and J. Ashby (1988). Species-specific response to the rodent carcinogens 1,2-dimethylhydrazine and 1,2-dibromo-3- chloropropane in rodent bone marrow micronucleus assay, Mutagenesis, 3, 35–38.
  • Shelby, M. D., G. L. Erexson, G. J. Hook, and R. R. Tice (1993). Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals, Environ. Mol. Mutagen., 21, 160–179.
  • You, Z., M. D. Brezzell, S. K. Das, M. C. Espadas-Torre, B. H. Hooberman, and J. E. Sinsheimer (1993). ortho-Substituent effects on the in vivo genotoxicity of benzidine derivatives, Mutat. Res., 319, 19–30.
  • Chrisman, C. L. and A. P. Baumgartner (1979). Cytogenetic effects of diethylstilbestrol-diphosphate (DES-dp) on mouse bone marrow monitored by the micronucleus test, Mutat. Res., 67, 157–160.
  • Pylkken, L., K. Jahnukainen, M. Parvinen, and R. Santti (1991). Testicular toxicity and mutagenicity of steroidal and non-steroidal estrogens in the male mouse, Mutat. Res, 261, 181–191.
  • Hayashi, M., S. Honda, and M. Watanabe (1981). Micronucleus test with synthesized food colours, Annu. Rep. Toyama Instit. Health, 4, 265–267.
  • Schop, R. N., M. H. Hardy, and M. T. Goldberg (1990). Comparison of the activity of topically applied pesticides and the herbicide 2,4-D in two short-term in vivo assays of genotoxicity in the mouse, Fundam. Appl. Toxicol., 15, 666–675.
  • Chieli, E., F. Aliboni, M. Saviozzi, and G. Malvaldi (1987). Induction of micronucleated erythrocytes by primary thioamides and their metabolites in the mouse, Mutat. Res., 192, 141–143.
  • Cihak, R. and M. Vontorkova (1990). Activity of acrylamide in single-, double-, and triple-dose mouse micronucleus assays, Mutat. Res., 234, 125–127.
  • Kirkhart, B. (1981). Micronucleus test on 21 compounds, In: F. J. de Serres and J. Ashby Eds. Evaluation of Short-Term Tests for Carcinogens, Elsevier, New York, pp. 698–704.
  • Przybojewska, B., E. Dziubaltowska, and Z. Kowalski (1984). Genotoxic effects of ethyl acrylate and methyl acrylate in the mouse evaluated by the micronucleus test, Mutat. Res., 135, 189–191.
  • Ashby, J. C. R. Richardson, and H. Tinwell (1989). Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assay, Mutagenesis, 4, 283–285.
  • Nandan, S. D. and M. S. Rao (1981) A study on the mutagenicity of phenobarbital using the micronucleus test in Swiss mice, IRCS Med. Sci., 9, 937–938.
  • Bruce, W. R. and J. A. Heddle (1979). The mutagenoc activity of 61 agents as determined by the micronucleus test, Salmonella, and sperm abnormality assays, Int. J. Cancer, 9. 435–451.
  • Mohtashamipur, E., R. Triebel, H. Straeter, and K. Norpoth (1987). The bone marrow clastogenicity of eight halogenated benzenes in NMRI mice, Mutagenesis, 2, 111–113.
  • Mirkova, E. (1990). Activity of the human carcinogens benzidine and 2-naphthylamine in triple-and single-dose mouse bone marrow micronucleus assays: results for a combined test protocol, Mutat. Res., 234, 161–163.
  • Vijayalaxmi, R., R. Tice, and G. H. S. Strauss (1992). Assessment of radiation-induced DNA damage in human lymphocytes using single cell gel electrophoresis technique, Mutat. Res., 271, 243–252.
  • Lee, J. G., M. C. Madden, W. Reed, K. Adler, and R. Devlin (1996). The use of the single cell gel electrophoresis assay in detecting DNA single strand breaks in lung cells in vitro, Toxicol. Appl. Pharmacol., 141, 195–204
  • JEMS.MMS (1996). Meeting abstract. Annual Meeting of the Japanese Environmental Mutagen Society (Tokyo).
  • Suzuki, T., T. Itoh, M. Hayashi, Y. Nishikawa, S. Ikezaki, F. Furukawa, M. Takahashi, and T. Sofuni (1996). Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice, Environ. Mol. Mutagen., 28, 348–353.
  • Suzuki, T., M. Hayashi, M. Ochiai, K. Wakabayashi, T. Ushijima, T. Sugimura, M. Nagao, and T. Sofuni (1996). Organ variation in the mutagenicity of MeIQ in Big Blue ™ lacI transgenic mice, Mutat. Res., 369, 45–49.
  • Lynch, A. M., N. J. Gooderham, and A. R. Boobis (1996). Organ distinctive mutagenicity in MutaMouse after short-term exposur to PhIP, Mutagenesis, 11, 505–509.
  • Ashby, J., P. A. Lefevre, H. Tinwell, G. Brunborg, P. Schmezer, B. Pool-Zobel, R. Shanu-Wilson, J. A. Holme, E. J. Soderlund, D. Gulati, and J. P. Wojciechowski (1991). The non-genotoxicity to rodents of the potent bladder carcinogens o-anisidine and p-cresidine, Mutat. Res., 250, 115–133.
  • Ashby, J., J. M. Short, N. J. Jones, P. A. Lefevre, G. S. Provost, B. J. Rogers, E. A. Martin, J. M. Parry, K. Burnette, B. J. Glickman, and H. Tinwell (1994). Mutagenicity of o-anisidine to the bladder of lacI-transgenic B6C3F1 mice: absence of 14C or 32p bladder DNA adduction, Carcinogenesis, 15, 2291–2296.
  • Hayward, J. J., B. S. Shane, K. R. Tindall and M. L. Cunningham (1995). Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene, Carcinogenesis, 16, 2429–2433.
  • Suzuki, T., S. Itoh, M. Nakajima, N. Hacjiya, and T. Hara (1999). Target organ and time-course in the mutagenicity of the five carcinogens in Muta™ Mouse: a summary report of the second collaborative study by of the transgenic mouse mutation assay by JEMS/MMS, Mutat. Res., 444, 259–268.
  • Brunborg, G., E. J. Søderlund, J. A. Halme, and E. Dybing (1996). Organ-specific and transplacental DNA damage and its repair in treated with 1,2-dibromo-3-chloropropane, Chem.-Biol. Interact., 101, 33–48.
  • G. A. Belitsky, T. A. Lycheva, I. A. Khitrovo, R. D. Safaev, V. S. Zhurkov, I. F. Vyskubenko, L. P. Sytshova, O. G. Salamatova, E. G. Feldt, V. V. Khudoley, E. M. Mizgirev, E. M. Khovanova, E. G. Uginivenko, T. B. Tanirbergerov, K. I. Malinovskaya, Yu. A. Revazova, F. I. Ingel, V. A. Bratlavsky, A. B. Terentyev, A. A. Shapiro, and G. M. Williams (1994). Genotoxicity and carcinogenicity testing of 1,2-dibromopropane and 1,1,3-tribromopropane in comparison to 1,2-dibromo-3-chloropropane, Cell Biol. Toxicol., 10, 265–279.
  • Ghia, M., L. Robbiano, A. Allavena, A. Martelli, and G. Brambilla (1993). Genotoxic activity of 1,3- dichloropropane in a battery of in vivo short-term tests, Toxicol. Appl. Pharmacol., 120, 120–125.
  • Brabbilla, G., M. Cavanna, S. Parodi, L. Sciaba, A. Pino, and L. Robbaiano (1978). DNA damage in liver, colon, stomach, lung and kidney of BALB/c mice treated with 1,2-dimethylhydrazine, Int. J. Cancer, 22, 174–180.
  • Zhurkov, V. S., L. P. Sycheva, O. Salamatova, I. F. Vyskubenko, E. G. Feldt, and N. I. Sherenesheva (1996). Selective induction of micronuclei in the rat/mouse colon and liver by 1,2-dimethylhydrazine: a seven-tissue comparative study, Mutat. Res., 368, 115–120.
  • Hakura, A., Y. Tsutsui, J. Sonoda, J. Kai, T. Imade, M. Shimada, Y. Sugihara, and T. Mikami (1998). Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse), Mutat. Res., 398, 123–130.
  • Galloway, S. M., A. D. Bloom, M. Resnick, B. H. Margolin, F. Nakamura, P. Archer, and E. Zeiger (1985). Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: comparison of results for 22 compounds in two laboratories, Environ. Mutagen., 1985, 7, 1–51.
  • Galloway, S. M., M. J. Armstrong, C. Reuben, S. Colman, B. Brown, C. Cannon., A. D. Bloom, F. Nakamura, M. Ahmed, S. Duk, J. Rimpo, B. H. Margolin, M. A. Resnick, B. Anderson, and E. Zeiger (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals, Environ. Mol. Mutagen., 10 (Suppl. 10), 1–175.
  • Sasaki, Y. F., H. Yamada, K. Shimoi, N. Kinae, I. Tomita, H. Matsumura, T. Ohta, and Y. Shirasu (1992). Enhancing effects of heterocyclic amines and ß-carbolines on the induction of chromosome aberrations in cultured mammalian cells, Mutat. Res., 269, 79–95.
  • Au, W. and T. C. Hsu (1979). Studies on the clastogenic effects of biologic stains and dyes, Environ. Mutagen., 1, 27–35.
  • Suzuki, T., M. Hayashi, T. Sofuni, and B. C. Myhr (1993). The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice, Mutat. Res., 285, 219–24.
  • Brooks, T. M., S. W. Dean, and D. J. Kirkland (1995). The detection of gene mutation in transgenic mice (Muta Mouse) following administration of known mutagens (Meeting abstract), Environ. Mol. Mutagen., 25 (Suppl 25), 6.
  • Suzuki, T., M. Hayashi, X. Wang, K. Yamamoto K, T. Ono, B. C. Myhr, and T. Sofuni (1997). A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta Mouse), Mutat. Res., 395, 75–82.
  • Brooks, T. M. and S. W. Dean (1996). Detection of gene mutation in skin, stomach and liver of MutaMouse following oral or topical treatment with N-methyl-N′- nitro-N-nitrosoguanidine or 1-chloromethylpyrene: some preliminary observations, Mutagenesis, 11, 529–532.
  • Butterworth, B. E., M. V. Templin, A. A. Constan, C. S. Sprankle, B. A. Wong, L. J. Pluta, J. I. Everitt, and L. Recio (1998). Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice, Environ. Mol. Mutagen. 31, 248–256.
  • Liegibel, U. M., P. Schmezer P, R. G. Klein, F. Kuchenmeister, and H. Bartsch (1998). Tissue-specific induction of mutations in transgenic mice after dimethyl nitrosamine (DMN) inhalation (Meeting abstract), Environ. Mol. Mutagen. 25 (Suppl 25), 30.
  • Bolognesi, C., C. F. Cesarone, and L. Santi (1981). Evaluation of DNA damage by alkaline elution technique after in vivo treatment with aromatic amines, Carcinogenesis, 2 265–268.
  • Davis, C. D., E. J. Dacquel, H. A. Schut, S. S. Thorgeirsson, and E. G. Snyderwine (1996). In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta Mice and c-myc/lacZ double transgenic mice, Mutat. Res., 356, 287–296.
  • Parodi, S. M. Pala, P. Russo, A. Zunino, C. Balbi, A. Albini, F. Valerio, M. R. Cimberle and L. Santi (1982). DNA damage in liver, kidney, bone marrow, and spleen of rats and mice treated with commercial and purified aniline as determined by alkaline elution as say and sister chromatid exchange induction, Cancer Res., 42, 2277–2283.
  • Douglas, G. R., J. D. Gingerich, and L. M. Soper (1995). Non-mutagenicity of l, l-trichloroethylene (TCE) and hydrazine sulfate (HS) in lung, liver and bone marrow of lacZ transgenic mice (Meeting abstract), Environ. Mol. Mutagen. 25 (Suppl. 25), 13.
  • Shephard, S. E., C. Sengstag, W. K. Lutz, and C. Schlatter (1993). Mutations in liver DNA of lacI transgenic mice (Big Blue) following subchronic exposure to 2-acetylaminofluorene (2AAF), Mutat. Res., 302, 91–96.
  • Bolognesi, C. M. R. Mariani, and L. C. Boffa (1988). Target tissue DNA damage in inbred mouse strains with different susceptibility to the colon carcinogen 1,2-dimethylhydrazine, Carcinogenesis, 9 1347–1350.
  • Itoh, S. and H. Shimada (1998). Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium, Mutat. Res., 412, 63–67.
  • Bolognesi, C., L. Rossi, O. Barbieri, and L. Santi (1985). Benzo[a]pyrene-induced DNA damage in mouse fetal tissues, Carcinogenesis, 6, 1091–1095.
  • Shane, B. S., A. M. Lockhart, G. W. Winston, and K. R. Tindall (1997). Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy, Mutat. Res., 377, 1–11.
  • Skopek, T. R., K. L. Kort, D. R. Marino, L. V. Mittal, D. R. Umbenhauer, G. M. Laws, and S. P. Adams (1996). Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big BlueB6C3F1 mice, Environ. Mol. Mutagen., 28, 376–384.
  • Monroe, J. J., K. L. Kart, J. E. Miller, D. R. Marino, and T. R. Skopek (1998). A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice, Mutat. Res., 421, 121–136.
  • Parodi, S., M. Taningher, M. Pala, and L. Santi (1981). Alkaline DNA fragmentation in vivo: borderline or negative results obtained, respectively, with 7, 12- dimethylbenz[a]anthracene (DMBA) and benzo[a]pyrene, Tumori., 67, 87–93.
  • Lee, E. W. and C. D. Garner (1991). Effects of benzene on DNA strand breaks in vivo versus benzene metabolite-induced DNA strand breaks in vitro in mouse bone marrow cells, Toxicol. Appl. Pharmacol., 108, 497–508.
  • Provost, G. S., J. C. Mirsalis, B. J. Rogers, and J. M. Short (1996). Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis, Environ. Mol. Mutagen., 28, 342–347.
  • Suter, W. F. Staedtler, F. Poetter-Locher, T. Swingler and L. Wilson (1998). 4-Chloro-o-phenylenediemine: a 26-week oral (in feed) mutagenicity study in Big Blue mice, Mutat. Res., 414, 149–156.
  • Olive, P. L., D. Wlodek, R. E. Durand, and J. P. Banath (1992). Factors influencing DNA migration from individual cells subjected to gel electrophoresis, Exp. Cell Res., 198, 259–267.
  • Pfuhler, S. and H. U. Wolf (1996). Detection of DNA-crosslinking agents with the alkaline comet assay, Environ. Mol. Mutagen., 27, 196–201.
  • Krebs, O and J. Favor (1997). Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea, Mutat. Res., 388, 239–248
  • Tsuda, S., N. Matsusaka, H. Madarame, S. Ueno, N. Susa, K. Ishida, N. Kawamura, K. Sekihashi, and Y. F. Sasaki (2000) The comet assay in eight mouse organs: Results with 24 azo compounds, Mutat. Res., 465, 11–26.
  • Tsuda, S., N. Matsusaka, S. Ueno, N. Susa, and Y. F. Sasaki (2000) The influence of antioxidants on cigarette smoke-induced DNA single strand breaks in mouse organs: a preliminary study with the alkaline single cell gel electrophoresis assay, Toxicol. Sci., 54, 104–109.
  • Tsuda, S., N. Matsusaka, H. Madarame, Y. Miyamae, K. Ishida, M. Satoh, K. Sekihashi, and Y. F. Sasaki (2000) The comet assay with mouse eight organs: results with 22 mono-functional alkylating agents (including 9 dialkyl N-nitrosoamines) and 10 DNA crosslinkers, Mutat. Res., 467, 83–97.
  • Sekihashi, K., Y. F. Sasaki, T. Maeda, K. Kawamura, T. Ikka, N. Matsusaka, and S. Tsuda, A comparison of intraperitoneal and oral gavage administration in comet assay in mouse eight organs, submitted to Mutat. Res.
  • http://ifpma.org/ichl.html).
  • ICH (1995). Topic 2A Genotoxicity; Guidance on specific aspect of regulatory genotoxicity testing of pharmaceuticals, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Step 4 Guidline (see Web site http://ifpma.org/ichl.html).
  • Madle, S., S. W. Dean, U. Andrae, G. Brambilla, B. Burlinson, D. J. Doolittle, C. Hertner, C. A. McQueen, and H. Mori, (1994). Recommendations for the performance of UDS tests in vitro and in vivo. Mutat. Res. 312, 263–285
  • Tweats, D. J. (1994). Follow-up of in vitro positive results. In: P. F. D. Arcy and D. W.G. Harron Eds. Proceedings of the Second International Conference on Harmonisation (ICH 2), Greystoke Books Ltd., N. Ireland, pp. 240–244.
  • Tice, R. R., E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H. Kobayashi, Y. Miyamae, E. Rojas, J-C. Ryu, and Y. F. Sasaki (2000). The Single Cell Gel/Comet Assay: Guidelines for in vitro and in vivo genetic toxicology testing, Environ. Mol. Mutag. 35, 206–221.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.